Fingerprint
Dive into the research topics of 'Phase III study of the Eastern Cooperative Oncology Group (ECOG 2597): Induction chemotherapy followed by either standard thoracic radiotherapy or hyperfractionated accelerated radiotherapy for patients with unresectable stage IIIA and B non-small-cell lung cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically